Role of pharmacokinetics in the development of medicinal products in the paediatric population

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberCHMP/EWP/147013/04
Published28/06/2006
Effective from01/01/2007
KeywordsChildren, extrapolation, dose finding, maturation, age, adolescents, newborns, infants, toddlers, pharmacokinetics
DescriptionThis document provides advice on the use of pharmacokinetic studies in paediatric drug development and on methodological issues concerning pharmacokinetic studies in paediatric patients.


Document history

Revision 1

Concept paper

Published: 04/05/2017

 

Deadline for comments: 31/07/2017

First version

Current version

Adopted guideline


 

Overview of comments

In operation: 01/01/2007-present


 

Published: 21/09/2006


Related content


How helpful is this page?

Average rating:

 Based on 1 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
1 ratings
    

Tell us more